May 04, 2010; 74 (18) Articles
The MG Composite
A valid and reliable outcome measure for myasthenia gravis
Ted M. Burns, Mark Conaway, Donald B. Sanders
First published May 3, 2010, DOI: https://doi.org/10.1212/WNL.0b013e3181dc1b1e
Ted M. Burns
Mark Conaway
The MG Composite
A valid and reliable outcome measure for myasthenia gravis
Ted M. Burns, Mark Conaway, Donald B. Sanders
Neurology May 2010, 74 (18) 1434-1440; DOI: 10.1212/WNL.0b013e3181dc1b1e
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 74 no. 18 1434-1440
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published May 3, 2010.
Copyright & Usage:
© 2010
Author Disclosures
- Ted M. Burns, MD,
- Mark Conaway, PhD,
- Donald B. Sanders, MD and
- On behalf of the MG Composite and MG-QOL15 Study Group
- Ted M. Burns, MD,
- Mark Conaway, PhD,
- Donald B. Sanders, MD and
- On behalf of the MG Composite and MG-QOL15 Study Group
- Address correspondence and reprint requests to Dr. Ted M. Burns, University of Virginia, Department of Neurology, PO Box 800394, Charlottesville, VA 22908 tmb8r{at}virginia.edu
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Development and validation of the Myasthenia Gravis Impairment IndexCarolina Barnett, Vera Bril, Moira Kapral et al.Neurology, July 08, 2016 -
Article
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label ExtensionRenato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al.Neurology, November 23, 2020 -
Article
Patient-acceptable symptom states in myasthenia gravisMeg Mendoza, Christopher Tran, Vera Bril et al.Neurology, August 05, 2020 -
Article
Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia GravisGuilhem Solé, Stéphane Mathis, Diane Friedman et al.Neurology, February 10, 2021